shire map
Select a
Location

Shire Global

Investor Relations

Second Quarter 2008 Results

Investor & Analyst meeting and conference call:
Angus Russell, Chief Executive Officer, Graham Hetherington, Chief Financial Officer, Mike Cola, President, Specialty Pharmaceuticals and Sylvie Grégoire, President, Human Genetic Therapies hosted the investor and analyst meeting and conference call at 14:30 BST/9:30 EDT.

Replay of the audio webcast.

Slide presentation to accompany the call

Q2 Press Release

« Back to Calendar

By following this link you will be leaving a Shire controlled website for a third party website. Please note that Shire is not responsible or liable for any third party website and the website may not be appropriate for all audiences.

By following this link you will be leaving the global Shire.com website for another Shire website. Please note that this website may not be appropriate for all audiences.

RETURN CONTINUE